Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

A new study suggests an enzyme unique to Homo sapiens may have made us more competitive water seekers than our closest ...

Yale researchers have developed a new and safe family of RNA-editing tools that utilize an RNA-targeting activity that they ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved Ionis Pharmaceuticals, Inc.’s (NASDAQ:IONS) Dawnzera ...

Studying the process of brain formation illuminates just how much of development is a series of tiny miracles. Only a few ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

According to the Cleveland Clinic, an American nonprofit academic medical centre, an mRNA vaccine trains your body to fight ...

"I am saddened and outraged that more citizens are not tuning into this war against scientific health research in the United ...

Robert F. Kennedy Jr. announced his department is killing nearly $500 million in contracts to develop new uses for mRNA ...